Greater Cannabis Company (GCAN) Cost of Revenue (2017 - 2026)

Greater Cannabis Company's Cost of Revenue history runs 10 years deep, the most recent figure standing at $3376.0 for Q1 2026.

• In Q1 2026, Cost of Revenue fell 70.17% year-over-year to $3376.0; the TTM figure through Mar 2026 stood at $52845.0 (up 51.44% YoY), while the FY2025 annual figure was $60788.0, up 94.36% from the prior year.
• Cost of Revenue was $3376.0 for Q1 2026 at Greater Cannabis Company, down from $23806.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $23806.0 in Q4 2025 to a low of $3376.0 in Q1 2026.
• Historically, Cost of Revenue has averaged $11637.6 across 5 years, with a median of $11017.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue sank 87.6% in 2022, then jumped 273.43% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $11017.0 in 2022, then increased by 15.98% to $12777.0 in 2023, then plunged by 50.11% to $6375.0 in 2024, then surged by 273.43% to $23806.0 in 2025, then sank by 85.82% to $3376.0 in 2026.
• The last three Cost of Revenue figures came in at $3376.0 (Q1 2026), $23806.0 (Q4 2025), and $7412.0 (Q3 2025), per Business Quant data.